Paula Schneider, CEO of @SusanGKomen: “The introduction of #biosimilars is an important step in increasing options… https://t.co/FD5MiVgKob
Paula Schneider, CEO of @SusanGKomen: “The introduction of #biosimilars is an important step in increasing options… https://t.co/FD5MiVgKob